Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
Log In | Register FREE | Register for Free Webinar | Solution Enquiry | Subscribe
Did you know?
What made us buy IEX@193, Tata Power@56, Titan@330, Divis@629, Persistent@700.
Webinar Webinar
investing succesffuly to reach your goals investing succesffuly to reach your goals
X

Auromed Ltd Stock Analysis

Small Cap
Evaluated by 5 users | BSE: 532103 | NSE: |
Pharmaceuticals & Drugs
Read More
10YEAR X-RAY

10 Year X-Ray

Standalone basis Standalone basis P Consolidated basis

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'02Mar'03Mar'04Mar'05TTM
Return on Capital Employed 0.03%0.05%0.2%0.91%-
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 0.40.40.41.52
Y-o-Y Gr. Rt.-8.1%-2.5%284.6%-
Adjusted EPS (Rs.) 00.010.020.090.09
Y-o-Y Gr. Rt.-NA100%350%-
Book Value per Share (Rs.) 9.369.379.589.7610.12
Adjusted Net Profit 0000.10
Net Op. Cash Flow (Rs. Cr.) -0.10-0.10.2-
Debt to Cash Flow from Ops -0.31-1.06-0.110.07-
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Auromed Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  10 yrs 5 yrs 3 yrs 1 yr
Net Sales NANA59.5%284.6%
Adjusted EPS NANANA350%
Book Value per Share 001.41.9
Share Price - - - -
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'02Mar'03Mar'04Mar'05TTM
Return on Equity (%) 0.030.050.190.910.91
Operating Profit Margin (%) 0.480.72-6.316.610
Net Profit Margin (%) 0.290.442.133.123.06
Debt to Equity 00.0100-
Working Capital Days 016021871-
Cash Conversion Cycle 0579131-
Price Chart
Loading price chart...
shareholding patterns

Shareholding Pattern

No Data To Display
shareholding patterns

Promoter's Holding & Share Pledging

shareholding patterns

FAQs

1. Is Auromed a good quality company?
Data is not available for this company.
2. Is current market price of Auromed a good price to buy it?

Data is not available for this company.

3. What is Auromed share price return in the past 10 years ?

Data is not available for this company

4. Is Auromed a good long term investment?

Data is not available for this company.

shareholding patterns

About Auromed

Auromed was incorporated in March 1995 as a public limited company promoted by D Srinivasvaradhan. The company is in the process of establishing a multipurpose bulk drug and pharmaceutical manufacturing plant at Guduvancheri in Tamilnadu. It came out with a public issue in June 1996 to part-finance this project. The company manufactures bronopol BP, norfloxacin BP and diclofenac sodium BP, betaine base and betaine hydrochloride BP.

Bronopol will be exported to

Read More

Auromed was incorporated in March 1995 as a public limited company promoted by D Srinivasvaradhan. The company is in the process of establishing a multipurpose bulk drug and pharmaceutical manufacturing plant at Guduvancheri in Tamilnadu. It came out with a public issue in June 1996 to part-finance this project. The company manufactures bronopol BP, norfloxacin BP and diclofenac sodium BP, betaine base and betaine hydrochloride BP.

Bronopol will be exported to European countries for which the company has firm marketing tie-up with Transtech International, UK; Herman Gshutte & Co, Germany and Pharmaco, Germany. Betaine base and betaine hydrochloride will also be exported through marketing agreement with Perry Pharmaceuticals, UK; Lab-Tech Pharma, Switzerland and Webster Pharma Technique, France . Norfloxacin and diclofenac sodium will be marketed in the domestic market.

The registered office of the company is located at Srinilayam 1, Kannaiah Street, T Nagar Chennai in Tamil Nadu.

Read Less
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback